Literature DB >> 9971834

Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

J Johnston1, C Power.   

Abstract

Feline immunodeficiency virus (FIV) is a lentivirus causing immune suppression and neurological disease in cats. Like primate lentiviruses, FIV utilizes the chemokine receptor CXCR4 for infection. In addition, FIV gene expression has been demonstrated in immortalized human cell lines. To investigate the extent and mechanism by which FIV infected primary and immortalized human cell lines, we compared the infectivity of two FIV strains, V1CSF and Petaluma, after cell-free infection. FIV genome was detected in infected human peripheral blood mononuclear cells (PBMC) and macrophages at 21 and 14 days postinfection, respectively. Flow cytometry analysis of FIV-infected human PBMC indicated that antibodies to FIV p24 recognized 12% of the cells. Antibodies binding the CCR3 chemokine receptor maximally inhibited infection of human PBMC by both FIV strains compared to antibodies to CXCR4 or CCR5. Reverse transcriptase levels increased in FIV-infected human PBMC, with detection of viral titers of 10(1.3) to 10(2.1) 50% tissue culture infective doses/10(6) cells depending on the FIV strain examined. Cell death in human PBMC infected with either FIV strain was significantly elevated relative to uninfected control cultures. These findings indicate that FIV can productively infect primary human cell lines and that viral strain specificity should be considered in the development of an FIV vector for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971834      PMCID: PMC104496     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells.

Authors:  M L Poss; S W Dow; E A Hoover
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion.

Authors:  S Koenig; V M Hirsch; R A Olmsted; D Powell; W Maury; A Rabson; A S Fauci; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Authors:  Y M Naidu; H W Kestler; Y Li; C V Butler; D P Silva; D K Schmidt; C D Troup; P K Sehgal; P Sonigo; M D Daniel
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells.

Authors:  S W Dow; M J Dreitz; E A Hoover
Journal:  Vet Immunol Immunopathol       Date:  1992-12       Impact factor: 2.046

7.  Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

8.  Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.

Authors:  T Miyazawa; Y Kawaguchi; M Kohmoto; J Sakuragi; A Adachi; M Fukasawa; T Mikami
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

9.  Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.

Authors:  E E Sparger; B L Shacklett; L Renshaw-Gegg; P A Barry; N C Pedersen; J H Elder; P A Luciw
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

10.  Molecular characterization and heterogeneity of feline immunodeficiency virus isolates.

Authors:  N Maki; T Miyazawa; M Fukasawa; A Hasegawa; M Hayami; K Miki; T Mikami
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more
  15 in total

Review 1.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

3.  Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.

Authors:  Dyana T Saenz; Wulin Teo; John C Olsen; Eric M Poeschla
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury.

Authors:  J B Johnston; C Silva; T Hiebert; R Buist; M R Dawood; J Peeling; C Power
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity.

Authors:  J B Johnston; Y Jiang; G van Marle; M B Mayne; W Ni; J Holden; J C McArthur; C Power
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Very low prevalence of bovine immunodeficiency virus infection in western Canadian cattle.

Authors:  G C Gonzalez; J B Johnston; D D Nickel; R M Jacobs; M Olson; C Power
Journal:  Can J Vet Res       Date:  2001-01       Impact factor: 1.310

7.  Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.

Authors:  J B Johnston; C Silva; C Power
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.

Authors:  J B Johnston; C Power
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Novel GP64 envelope variants for improved delivery to human airway epithelial cells.

Authors:  P L Sinn; B-Y Hwang; N Li; J L S Ortiz; E Shirazi; K R Parekh; A L Cooney; D V Schaffer; P B McCray
Journal:  Gene Ther       Date:  2017-09-07       Impact factor: 5.250

Review 10.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.